Wezlana Injection, Solution
Product Images NDC 84612-889

Product Visual Gallery

This gallery contains 41 technical images submitted to the FDA as part of the official labeling for Wezlana (NDC 84612-889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nuvaila Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Wezlana 01)

A labeled black and white diagram of a prefilled injection syringe. Key parts shown include the plunger rod and head, needle guard clips, finger grip, body with viewing window and label, and a needle cap containing the needle inside. The diagram illustrates structural components and their locations on the syringe.*

FDA Label Image

Figure (Wezlana 02)

An instructional illustration showing a hand removing or handling a safety cap from a syringe or injection device, demonstrating proper preparation technique for an INJECTION, SOLUTION dosage form.*

FDA Label Image

Figure (Wezlana 03)

An instructional black-and-white illustration depicting a hand holding a syringe with a safety cap being removed or engaged, indicated by a large arrow pointing to the plunger area. The image likely demonstrates a step in preparing an intravenous injection.*

FDA Label Image

Figure 1 (Wezlana 04)

Line graph titled 'PsA STUDY 1' showing percentage of patients over 24 weeks comparing Placebo, Ustekinumab 45 mg, and Ustekinumab 90 mg. The x-axis represents weeks, and the y-axis represents the percentage of patients. Data points indicate higher patient percentages for both Ustekinumab groups versus placebo.*

FDA Label Image

Figure (Wezlana 05)

An instructional diagram labeling the parts of a syringe for intravenous injection. The labeled components include plunger head, plunger rod, needle guard clips, finger grip, label, body, viewing window, and needle cap (with needle inside). The plunger location is also noted as variable.*

FDA Label Image

Figure (Wezlana 06)

An illustration of an intravenous injection device or syringe assembly, shown in cross-section. It features a purple plunger, a barrel holding the solution, and a needle at the end for intravenous administration. No specific product labels or text are visible on the device.*

FDA Label Image

Figure (Wezlana 07)

A cross-sectional illustration of a syringe or injection device showing internal components such as plunger, barrel, and needle assembly. The image highlights the structural details of the injection mechanism, likely related to an intravenous solution administration device.*

FDA Label Image

Figure (Wezlana 08)

An instructional diagram showing a carton with an arrow pointing to it, indicating that the product should be refrigerated in the carton until ready to use.*

FDA Label Image

Figure (Wezlana 09)

An instructional diagram showing the proper method of handling a syringe from a blister pack. The illustration highlights a hand pressing a latch or release mechanism on the syringe, indicating how to unlock or remove it from the packaging.*

FDA Label Image

Figure (Wezlana 10)

A circular timer graphic showing a 30-minute countdown. The timer is half shaded in blue, indicating the passage of time up to 30 minutes. The center of the graphic prominently displays '30 minutes' in black text.*

FDA Label Image

Figure (Wezlana 11)

Illustration of a calendar page displaying "30 days" prominently, likely indicating a 30-day period or cycle.*

FDA Label Image

Figure (Wezlana 12)

An instructional illustration showing a sharps disposal container along with labeled items: an alcohol wipe, an adhesive bandage, and a cotton ball or gauze pad. This supports safe disposal and care practices related to injection use.*

FDA Label Image

Figure (Wezlana 13)

An instructional diagram showing a syringe with a focus on the plunger and barrel. A zoomed-in section highlights the medicine inside the syringe. The label 'Medicine' points to the liquid contained within the syringe barrel, indicating the solution ready for intravenous injection.*

FDA Label Image

Figure (Wezlana 14)

Illustration showing a syringe with a zoomed-in inset highlighting the location where the lot number and expiration date are printed on the syringe barrel for drug identification and tracking.*

FDA Label Image

Figure (Wezlana 15)

An instructional anatomical diagram showing preferred injection sites on a human figure. Highlighted areas in blue include the abdomen, upper outer arms, and the front of the thighs, indicating intended locations for subcutaneous injection administration.*

FDA Label Image

Figure (Wezlana 16)

An instructional illustration showing two hands being washed with soap and water, bubbles visible around the hands to indicate cleansing action.*

FDA Label Image

Figure (Wezlana 17)

An instructional illustration showing a hand pressing or peeling a flat, rectangular object, likely demonstrating how to open a medication packaging or apply a patch or adhesive relevant to drug administration.*

FDA Label Image

Figure (Wezlana 18)

An instructional illustration showing two hands holding a syringe and a needle cap, with an arrow indicating the removal of the needle cap from the syringe. The image demonstrates a step in the preparation of an injection, likely for the intravenous administration of WEZLANA (ustekinumab-auub).*

FDA Label Image

Figure (Wezlana 19)

An instructional illustration showing a hand pinching the skin on another person's forearm, likely demonstrating a technique related to injection or intravenous drug administration.*

FDA Label Image

Figure (Wezlana 20)

An instructional illustration showing a hand administering an injection at a 45-degree angle into the skin of the opposite hand, with a blue arrow highlighting the injection site. The image visually demonstrates correct injection technique.*

FDA Label Image

Figure (Wezlana 21)

An instructional illustration demonstrating the intravenous injection technique, showing a syringe being inserted into a patient's arm vein with an arrow indicating the direction of injection.*

FDA Label Image

Figure (Wezlana 22)

An instructional illustration showing a person holding and manipulating a syringe-like device, highlighting the correct grip and positioning for use with a detailed arrow indicating a motion or step, likely related to priming or preparing the injection device for administration.*

FDA Label Image

Figure (Wezlana 23)

An instructional illustration showing a hand holding a syringe with a removable cap, positioned near an open container with a flip-top lid. A blue arrow indicates the syringe is being inserted into the container opening, suggesting a step for preparing or accessing the injection solution.*

FDA Label Image

Figure (Wezlana 24)

An illustration showing a bandage and three cotton balls or small gauze pads. The image likely depicts basic wound care supplies or aftercare materials.*

FDA Label Image

Figure A (Wezlana 25)

Illustration showing components for WEZLANA (ustekinumab-auub) intravenous injection preparation and administration. Items depicted include an adhesive bandage, alcohol wipes, cotton balls or gauze pads, a WEZLANA vial, a syringe with attached needle, and an FDA-cleared sharps disposal container.*

FDA Label Image

Figure B (Wezlana 26)

An illustration depicting the human body with blue highlighted areas indicating injection sites for administering WEZLANA (ustekinumab-auub). The highlighted injection areas include the abdomen and the front of both thighs, shown on a simplified gray human figure.*

FDA Label Image

Figure C (Wezlana 27)

An illustration showing a vial with a removable flip-off cap, depicted by an arrow indicating the cap is being lifted off the vial. The image suggests the initial step for accessing the vial contents.*

FDA Label Image

Figure D (Wezlana 28)

Illustration showing a person's hands removing a protective cap from the top of a medication vial, depicting part of the preparation process for an intravenous injection.*

FDA Label Image

Figure E (Wezlana 29)

An instructional illustration showing two hands: one holding a needle cap about to be pulled off, and the other holding a syringe. Blue arrows indicate the direction to remove the needle cap from the syringe prior to injection.*

FDA Label Image

Figure F (Wezlana 30)

An instructional illustration showing a hand holding a vial and another hand drawing liquid from the vial into a syringe, demonstrating the process of preparing an injection solution for intravenous administration.*

FDA Label Image

Figure G (Wezlana 31)

An instructional illustration showing two hands preparing an injection. One hand is holding a vial upside down, while the other hand is drawing solution from the vial into a syringe, depicting the process of medication preparation for intravenous administration.*

FDA Label Image

Figure H (Wezlana 32)

Illustration showing two hands preparing an injection; one hand holds a vial upside down while the other holds a syringe drawing liquid from the vial. Blue curved lines near the connection point emphasize the action of drawing the solution into the syringe.*

FDA Label Image

Figure I (Wezlana 33)

An instructional illustration depicting the administration of an intravenous injection. The image shows a hand holding a syringe at a 45-degree angle, preparing to inject into a person's knee area, with the other hand stabilizing the injection site.*

FDA Label Image

Figure J (Wezlana 34)

An illustration showing a hand holding a syringe and inserting the needle into a patient's arm, indicating the administration of an injection.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Syringe Carton)

WEZLANA (ustekinumab-auub) injection label for the 45 mg/0.5 mL strength. The label indicates it is for subcutaneous use only, with storage instructions at 2° to 8°C (36° to 46°F). The label includes warnings such as do not shake or freeze, and to keep out of reach of children and protected from light. It also notes the product contains a single-dose prefilled syringe and is manufactured for Nuvaila Limited.*

FDA Label Image

Principal Display Panel (90 mg/mL Syringe Carton)

Label for WEZLANA (ustekinumab-auub) Injection, 90 mg/mL strength, presented in a single-dose prefilled syringe. The label indicates subcutaneous use only and includes storage instructions to keep refrigerated at 2° to 8°C (36° to 46°F). It is manufactured for Nuvaila Limited and notes the product is sterile with no preservative.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Vial Carton)

Label for WEZLANA (ustekinumab-auub) Injection 45 mg/0.5 mL, a subcutaneous injection. The label includes dosing strength, usage instructions emphasizing subcutaneous use, refrigeration storage conditions, and safety precautions. Manufactured for Nuvaila, the label also notes a single-dose vial, no preservative, and Rx only status.*

FDA Label Image

Principal Display Panel (130 mg/26 mL Vial Carton)

Label for WEZLANA (ustekinumab-auub) injection, solution at 130 mg/26 mL strength. The label indicates the product is for intravenous infusion only and must be diluted. It includes storage instructions to keep refrigerated between 2°C and 8°C, protect from light, and not to freeze or shake. Manufactured for Nuvaila Limited.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Syringe Carton)

Label for WEZLANA (ustekinumab-auub) Injection, 45 mg/0.5 mL, single-dose prefilled syringe. The label includes usage instructions emphasizing subcutaneous use, storage conditions (2° to 8°C), and warnings to keep out of children's reach and protect from light. Manufactured for Nuvaila Limited. NDC 84612-876-01.*

FDA Label Image

Principal Display Panel (90 mg/mL Syringe Carton)

Label for WEZLANA (ustekinumab-auub) injection, 90 mg/mL strength. The label indicates this is an injection solution manufactured for Nuvaila Limited, intended for subcutaneous use. It includes storage instructions to refrigerate between 2° to 8°C and cautions against shaking or freezing. The product is provided in a single-dose prefilled syringe.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Vial Carton)

Label for WEZLANA (ustekinumab-auub) Injection, 45 mg/0.5 mL, manufactured for Nuvaila Limited. The label indicates it is a single-dose vial for subcutaneous use only, with storage instructions to keep refrigerated at 2°C to 8°C and to avoid shaking or freezing. It includes warnings to keep out of reach of children and to dispense the enclosed Medication Guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.